the supplier base in emerging markets
The Alliance is playing an active role in encouraging manufacturers based in emerging market economies to enter the vaccine market. In 2012, GAVI started buying pentavalent vaccine from the Indian manufacturer Bio-E, thus opening up a new supply channel for a vaccine that has had issues with supply reliability in recent years.
LG Life Science, a vaccine manufacturer based in the Republic of Korea, was successful in obtaining WHO prequalification for its pentavalent vaccine. By ensuring access to more low-cost pentavalent vaccine products, GAVI and developing countries will be able to prevent even more deaths.
In 2012, the Chief Executive Officer of the GAVI Alliance, Dr Seth Berkley, met with Chinese vaccine manufacturers for the first time.
Access other stories: